Generic Name: betaxolol
Common side effects of Kerlone include: headache. Other side effects include: bradycardia.  See below for a comprehensive list of adverse effects.
Applies to betaxolol: oral tablet
In addition to its needed effects, some unwanted effects may be caused by betaxolol (the active ingredient contained in Kerlone). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking betaxolol:

If any of the following symptoms of overdose occur while taking betaxolol, get emergency help immediately:

Some of the side effects that can occur with betaxolol may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to betaxolol: oral tablet
The more commonly reported side effects include bradycardia, fatigue, lethargy, and headache.[Ref]
Bradycardia occurred as a dose-related effect in clinical trials.  In clinical trials, bradycardia occurred in 8.1% of patients given this drug compared to 12% of patients given equivalent doses of atenolol.  Symptomatic bradycardia occurred in 0.8% of patients taking this drug versus 1.4% of patients treated with equivalent doses of propranolol.  Angina pectoris, arrhythmia, AV block, heart failure, hypertension, hypotension, myocardial infarction, thrombosis, syncope, cerebrovascular disorder, intermittent claudication, peripheral ischemia, and thrombophlebitis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Common (1% to 10%): Chest pain, bradycardia, edema, palpitations, cold extremitiesFrequency not reported: Angina pectoris, arrhythmia, atrioventricular (AV) block, heart failure, hypertension, hypotension, myocardial infarction, thrombosis, thrombophlebitis, peripheral ischemia, intermittent claudication[Ref]
Bronchitis, bronchospasm, cough, epistaxis, pneumonia, and sinusitis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Common (1% to 10%): Dyspnea, pharyngitis, rhinitis, upper respiratory infectionFrequency not reported: Bronchitis, bronchospasm, cough, epistaxis, pneumonia, sinusitis[Ref]
Twitching, arthropathy, neck pain, muscle cramps, tendonitis, and leg cramps occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Common (1% to 10%): Joint pain, myalgia, arthralgiaFrequency not reported: Twitching, arthropathy, neck pain, muscle cramps, tendonitis, leg cramps[Ref]
Ataxia, neuralgia, neuropathy, numbness, speech disorder, stupor, tremor, syncope, amnesia, impaired concentration, taste loss, cerebrovascular disorder, and abnormal taste occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Common (1% to 10%): Headache, dizziness, paresthesia, lethargyFrequency not reported: Ataxia, neuralgia, neuropathy, numbness, speech disorder, stupor, tremor, syncope, amnesia, impaired concentration, taste loss, cerebrovascular disorder, abnormal taste[Ref]
Salivation, mouth ulceration, dry mouth, rectal disorders, vomiting, dysphagia, and constipation occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Common (1% to 10%): Nausea, dyspepsia, diarrheaFrequency not reported: Salivation, mouth ulceration, rectal disorders, vomiting, dysphagia, constipation, dry mouth[Ref]
Frequency not reported: Anemia, leukocytosis, lymphadenopathy, thrombocytopenia[Ref]
Anemia, leukocytosis, lymphadenopathy, and thrombocytopenia occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Menstrual disorder, Peyronie's disease, prostatitis, proteinuria, dysuria, and micturition disorder occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Common (1% to 10%): ImpotenceFrequency not reported: Menstrual disorder, Peyronie's disease, prostatitis, proteinuria, micturition disorder, dysuria[Ref]
Flushing, sweating, purpura, pruritus, skin disorders, hypertrichosis, erythematous rash, eczema, and alopecia occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Common (1% to 10%): RashFrequency not reported: Flushing, sweating, purpura, skin disorders, hypertrichosis, erythematous rash, eczema, alopecia, pruritus[Ref]
In clinical trials, ANA conversion occurred in 5.3%, 6.3%, 4.9%, and 3.2% of patients taking this drug, atenolol, propranolol, and placebo, respectively.  Flu occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience[Ref]
Common (1% to 10%): Antinuclear antibody (ANA) developmentFrequency not reported: Flu[Ref]
Uncommon (0.1% to 1%): Nervousness, bizarre dreams, depression, insomniaFrequency not reported: Abnormal thinking, confusion, emotional lability, hallucinations, decreased libido[Ref]
Abnormal thinking, confusion, emotional lability, hallucinations, and decreased libido occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Anorexia, increased appetite, acidosis, hypercholesterolemia, hyperglycemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypokalemia, weight gain, weight loss, increased LDH, diabetes occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Frequency not reported: Anorexia, increased appetite, hypercholesterolemia, hyperglycemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypokalemia, weight gain, weight loss, increased LDH, acidosis, diabetes[Ref]
Frequency not reported: Scotoma, ocular hemorrhage, iritis, dry eyes, conjunctivitis, cataract, blepharitis, abnormal lacrimation, abnormal vision[Ref]
Scotoma, ocular hemorrhage, iritis, dry eyes, conjunctivitis, cataract, blepharitis, abnormal lacrimation, and abnormal vision occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Frequency not reported: Fever, malaise, pain, rigors, asthenia, fatigue, earache, labyrinth disorders, deafness, thirst, breast pain, tinnitus[Ref]
Fever, malaise, pain, rigors, earache, labyrinth disorders, deafness, thirst, breast pain, and tinnitus occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Frequency not reported: Renal pain, oliguria, cystitis, abnormal renal function[Ref]
Renal pain, oliguria, cystitis, and abnormal renal function occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Increased liver transaminases occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Frequency not reported: Increased liver transaminases[Ref]
Frequency not reported: Breast fibroadenosis[Ref]
Breast fibroadenosis occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Allergy occurred in less than 2% of patients treated with this drug in open and controlled long-term clinical studies or in marketing experience.[Ref]
Frequency not reported: Allergy[Ref]
1. "Product Information. Kerlone (betaxolol)." Searle, Skokie, IL. 
Not all side effects for Kerlone may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Chest pain or discomfort
lightheadedness, dizziness, or fainting
shortness of breath
slow or irregular heartbeat
unusual tiredness


Cold arms, legs, hands, or feet
difficult or labored breathing
fast, pounding, or racing heartbeat or pulse
swelling of face, fingers, feet, or lower legs
tightness in the chest
wheezing


Anxiety
blurred vision
chills
cold sweats
coma
confusion
convulsions (seizures)
cool, pale skin
decreased urine output
depression
dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly
extreme fatigue
headache
increased hunger
irregular breathing
loss of consciousness
nervousness
nightmares
noisy breathing
shakiness
slurred speech
sweating
troubled breathing
weight gain
unusual tiredness or weakness


Joint pain
nausea


Acid or sour stomach
belching
body aches or pain
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
congestion
decreased interest in sexual intercourse
diarrhea
difficulty in moving
dryness or soreness of throat
fever
heartburn
hoarseness
inability to have or keep an erection
indigestion
loss in sexual ability, desire, drive, or performance
muscle pain or stiffness
rash
runny nose
sleeplessness
sneezing
stomach discomfort, upset, or pain
stuffy nose
tender, swollen glands in neck
trouble in swallowing
trouble sleeping
unable to sleep
unusual drowsiness, dullness, or feeling of sluggishness
unusual or strange dreams
voice changes


Discouragement
feeling sad or empty
irritability
lack of appetite
loss of interest or pleasure
tiredness
trouble concentrating

